Search clinical trials for: Ferric derisomaltose

Total 400 results

Instituto do Cancer do Estado de São Paulo
Fundação Faculdade de Medicina

Unknown

Iron Supplement in the Prevention of Anemia in Female Breast Cancer Patients

Breast Cancer

Brazil
Vifor Pharma
ICON Clinical Research; American Regent, Inc.

Completed

Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (FIND-CKD)

Chronic Kidney Disease | Iron Deficiency Anaemia

United Kingdom, United States, Australia, Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Italy, Netherlands, Norway, Poland, Portugal, Romania, Spain, Sweden, Turkey
Albion
Sprim Advanced Life Sciences

Unknown

A Study to Compare the Gastrointestinal Tolerability of Ferrochel®, Sumalate®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and Placebo

Anemia

Indonesia
Nottingham University Hospitals NHS Trust

Completed

Intravenous Iron: Measuring Response in Anemic Surgical Patients

Anemia | Colorectal Neoplasm

United Kingdom
St. Bartholomew's Hospital

Unknown

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

Lymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm

United Kingdom
Wayne State University
Children's Hospital of Michigan; American Regent, Inc.

Withdrawn

IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD

Iron Deficiency Anemia | Inflammatory Bowel Disease

United States
Vifor Pharma

Completed

Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy (FID-CHEMO)

Iron-Deficiency Anemia

Germany, Sweden
Medical Research Council

Completed

A Pilot Study to Assess the Influence of Dietary Organic Acids on Iron Absorption.

Iron Deficiency Anaemia

United Kingdom
Pharmacosmos A/S

Completed

Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel Disease

Inflammatory Bowel Disease
Pharmacosmos A/S

Completed

Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous to Patients With CKD (PK-CKD-03)

Non-dialysis Dependent Chronic Kidney Disease
Swiss Federal Institute of Technology
Swiss National Science Foundation; Swiss Tropical & Public Health Institute

Completed

Efficacy of Iron Fortified Complementary Food and IPT of Malaria in Young Children in Côte d'Ivoire

Anemia

Côte D'Ivoire
Seoul National University Bundang Hospital

Completed

Perioperative Iron With Erythropoietin in Bilateral Total Knee Replacement Arthroplasty (TKRA) (SNUBH)

Anemia | Transfusion

Korea, Republic of
Assistance Publique - Hôpitaux de Paris

Completed

Evaluation of Oxidative Stress Induced by Iron Injection in Healthy Volunteers and Critical Care Patients (SOFI)

Critical Illness

France
University Hospital Muenster
Vifor Pharma

Terminated

Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery (PRIVIRON)

Anemia | Orthopedic Surgery | High Risk of Blood Loss

Germany
International Centre for Diarrhoeal Disease Research...
Nestlé Foundation; Nutrition Third World, Belgium

Completed

Ferrous Fumarate and Ferric Pyrophosphate as Food Fortificants in Developing Countries

Helicobacter Pylori Infection | Healthy Participants | Non-anemic Children
Watson Pharmaceuticals

Completed

2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.

Iron Deficiency Anemia

United States, Canada, Mexico, Bulgaria, India, Russian Federation, Croatia, Poland
Pharmacosmos A/S

Completed

Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (CIA) (PK-CIA-04)

Non-hematological Malignancies
University of Zurich
Vifor Pharma

Terminated

Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery

Iron Deficiency Anemia

Switzerland
Soroka University Medical Center

Unknown

Serum NGAL Levels in Hemodialysis (HD) Patients; Relation to Iron Status, HD and Intravenous (IV) Iron Administration

Renal Failure Chronic Requiring Hemodialysis

Israel
University of Aarhus
Vifor Pharma; GCP-unit at Aarhus University Hospital, Aarhus, Denmark

Completed

Iron Substitution After Upper Gastro-Intestinal Bleeding

Anemia | Gastrointestinal Hemorrhage

Denmark
National Research Council, Spain
Ministry of Science and Innovation, Spain; Grupo Leche Pascual; Madrid Salud,...

Completed

Iron Fortified Beverages and Application in Women Predisposed to Anemia (FeDrink)

Iron-deficiency Anemia
Vifor Pharma
Parexel; ClinStar, LLC

Completed

FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR (FER-IBD-COR)

Anemia | Crohn's Disease | Ulcerative Colitis | Iron Deficiency | Inflammatory Bowel Disease | Iron-Deficiency Anemia

Austria
Vifor Pharma
SGS S.A.

Completed

Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age (Prefer)

Iron Deficiency

Austria
Watson Pharmaceuticals

Completed

Effect of Two Iron Preparations on Protein in the Urine

Anemia, Iron-Deficiency | Kidney Failure, Chronic

United States
Watson Pharmaceuticals

Completed

Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients

Anemia

United States, Poland, Mexico, Serbia, Russian Federation
JW Pharmaceutical

Completed

Efficacy and Safety Study of Iron Sucrose and Oral Iron Acetyl-transferrin Hydroglycerin

Iron Deficiency Anemia

Korea, Republic of
Watson Pharmaceuticals

Completed

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents

Anemia, Iron-Deficiency | Kidney Failure, Chronic

United States, Puerto Rico
Watson Pharmaceuticals

Completed

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients

Anemia, Iron-Deficiency | Kidney Failure, Chronic

United States, Puerto Rico
Watson Pharmaceuticals

Completed

Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy

Anemia

United States
Norwegian University of Science and Technology
St. Olavs Hospital; Sykehuset Innlandet HF; Sykehuset Buskerud HF

Terminated

Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum Anemia

Anemia, Iron-Deficiency | Depression, Postpartum | Puerperal Disorders

Norway
Ain Shams University

Unknown

Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload

Sickle Cell Disease | Beta-thalassemia Major | Iron Hemosiderosis

Egypt
Watson Pharmaceuticals

Completed

Comparison Between Effects of Two Iron Preparations on Protein in the Urine

Anemia, Iron-Deficiency | Kidney Failure, Chronic

United States, Puerto Rico
Enzon Pharmaceuticals, Inc.

Terminated

A Multicenter Study Evaluating the Safety and Tolerability of Intravenous rhMBL in Liver Transplant Recipients.

Liver Transplantation

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

Lymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Lymphoproliferative Disorder

United States
Amsterdam UMC, location VUmc
Vifor Pharma

Unknown

Iron Deficiency In Pulmonary Hypertension

Idiopathic Pulmonary Arterial Hypertension

Netherlands
Vifor Pharma

Terminated

Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)

Thrombocytosis | Iron-Deficiency Anemia

Austria
Hospital Clinic of Barcelona

Unknown

Efficacy and Safety of Intravenous Iron Sucrose in Patients With Hip Fracture to Prevent Perioperative Anemia

Hip Fracture | Surgical Intervention

Spain
University of Liege
KU Leuven; Amgen; Vrije Universiteit Brussel

Completed

Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)

Hematological Malignancies

Belgium
Watson Pharmaceuticals

Completed

Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients

Anemia

United States
University of Oxford
Universidad Peruana Cayetano Heredia

Completed

Study of the Effects of Iron Levels on the Lungs at High Altitude

Pulmonary Hypertension | Mountain Sickness

Peru
London Health Sciences Centre

Suspended

Trial Comparing the Safety of Two Different Intravenous Iron Formulations

Iron Deficiency Anemia | Perioperative Blood Conservation

Canada
Quadram Institute Bioscience
The Coca-Cola Company

Completed

Relative Bioavailability of Ferric Pyrophosphate From an Apple Juice Drink

Iron Deficiency

United Kingdom
University of Toronto
The Hospital for Sick Children; Heinz Endowments

Completed

Relative Bioavailability of Iron and Folic Acid in New Test Supplement

Iron Deficiency | Folic Acid Deficiency

Canada
Sundsvall Hospital

Completed

Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.

Multiple Myeloma | Anemia | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma

Sweden
Papageorgiou General Hospital

Completed

Changes in Iron Markers Following Iron Loading in Hemodialysis Patients

Anemia in Chronic Renal Disease

Greece
Institut Claudius Regaud

Terminated

Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced

Neoplasms | Anemia

France
Hospital de Clinicas de Porto Alegre

Unknown

Iron Supplementation in Heart Failure Patients With Anemia: The IRON-HF Study

Heart Failure | Anemia

Brazil
University Hospital Muenster

Unknown

Intravenous Iron in Patients With Anemia of Chronic Kidney Disease

Kidney Failure, Chronic

Germany
J. Uriach and Company

Unknown

Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.

Colorectal Neoplasm | Iron Deficiency Anemia

Spain
National Heart and Lung Institute
Wexham Park Hospital; 4th Military Hospital

Unknown

Effect of Intravenous Ferrous Sucrose on Exercise Capacity in Chronic Heart Failure

Heart Diseases | Anemia, Iron-Deficiency | Chronic Heart Failure

Poland, United Kingdom

Search clinical trials for: Ferric derisomaltose

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations